How Continuous Glucose Monitors Went From Diabetes to Wellness

Lucas and Luna explore the explosive growth of continuous glucose monitors beyond diabetes management. Lucas explains how Abbott's Freestyle Libre and Dexcom's G7 are now being marketed to 'health optimizers' and athletes. He breaks down the key numbers: the total addressable market expanding from 30 million diabetics to 400 million pre-diabetics plus millions of wellness consumers. Luna questions the evidence base — does real-time glucose data actually improve outcomes in non-diabetics? Lucas cites early studies from Levels and NutriSense showing behavioral changes but acknowledges the 'data for data's sake' criticism. They discuss the regulatory path: the FDA's 2024 clearance of over-the-counter CGMs and what it means for the category. A focused look at how a medical device is becoming a consumer health gadget and whether the science is keeping up. #ContinuousGlucoseMonitor #CGM #Abbott #Dexcom #FreestyleLibre #DexcomG7 #Levels #NutriSense #Wearables #DigitalHealth #Wellness #HealthTech #FDA #GlucoseMonitoring #Business #Technology #FexingoBusiness #BusinessPodcast Keep every episode free: buymeacoffee.com/fexingo